Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bright Minds Biosciences Inc

27.58
-0.8000-2.82%
Post-market: 27.580.00000.00%19:46 EDT
Volume:10.22K
Turnover:286.39K
Market Cap:195.36M
PE:-63.35
High:28.70
Open:27.75
Low:27.51
Close:28.38
Loading ...

Bright Minds Biosciences (DRUG) Receives a Buy from Chardan Capital

TIPRANKS
·
21 May

Bright Minds announces speakers for Absence epilepsy R&D Day

TIPRANKS
·
20 May

Bright Minds Biosciences Says BMB-101 Eliminated Drop Attacks in Mouse Model of Epilepsy

MT Newswires Live
·
13 May

TD Cowen Initiates Coverage on Bright Minds Biosciences With Buy Rating

MT Newswires Live
·
13 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 May

Bright Minds initiated with a Buy at TD Cowen

TIPRANKS
·
13 May

Bright Minds Biosciences’ BMB-101: A Promising Anti-Seizure Drug with Billion-Dollar Market Potential

TIPRANKS
·
13 May

Chardan Initiates Bright Minds Biosciences at Buy With $80 Price Target

MT Newswires Live
·
07 May

Chardan Capital Initiates a Buy Rating on Bright Minds Biosciences (DRUG)

TIPRANKS
·
07 May

Bright Minds Biosciences to Host Virtual R&D Day on May 20, 2025; Program Highlights Include an Overview of Absence Seizures and the BMB-101 Phase 2 Study

GlobeNewswire
·
28 Apr

Psychedelic: Clearmind completes clinical site initiations for AUD trial

TipRanks
·
25 Apr

Psychedelic: Exclusive talk with biotech company Clearmind Medicine

TipRanks
·
22 Mar

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial

TipRanks
·
14 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
11 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
07 Mar

SCIENTURE to commercially launch REZENOPY®, a life-saving opioid overdose emergency treatment through a collaboration with KINDEVA DRUG DELIVERY L.P.

GlobeNewswire
·
06 Mar

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Leaders in Epilepsy Research

GlobeNewswire
·
04 Mar

Bright Minds Biosciences to Participate at Three Healthcare Conferences in March

GlobeNewswire
·
24 Feb

Piper Sandler Initiates Bright Minds Biosciences at Overweight

MT Newswires Live
·
23 Jan

Yasmeen Rahimi’s Buy Rating on Bright Minds Biosciences Driven by Promising Potential of BMB-101 for Epilepsy Treatment

TIPRANKS
·
23 Jan